×
About 1,783 results

ALLMedicine™ Transferrin Saturation Center

Research & Reviews  630 results

Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis...
https://doi.org/10.1002/ejhf.2557
European Journal of Heart Failure; Kvaslerud AB, Bardan S et. al.

May 18th, 2022 - The aim of this trial was to evaluate whether intravenous iron could provide benefit beyond transcatheter aortic valve implantation (TAVI) in iron deficient patients with severe aortic stenosis. In this randomised, placebo-controlled, double-blind...

FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
https://clinicaltrials.gov/ct2/show/NCT05356325

May 2nd, 2022 - 1 Study populations 1.1) Study in patients with iron deficiency anemia with normal renal function. The study will be carried out in the serum samples of patients. All patients will be provided with the corresponding informed consent. Patients with...

Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typic...
https://doi.org/10.1159/000523947
American Journal of Nephrology; Goodkin DA, Zhao J et. al.

Apr 25th, 2022 - This study examines factors associated with erythropoiesis-stimulating agent (ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new episodes, and variation across countries. We used international Dialysis Outcomes a...

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
https://clinicaltrials.gov/ct2/show/NCT01114139

Apr 21st, 2022 - This Phase III, randomized, double-blind, placebo-controlled, multicenter clinical study evaluated the safety and efficacy of ferumoxytol compared with placebo for the treatment of IDA, specifically in adult patients with IDA who have a history of...

Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Pros...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982399
The Oncologist; Gluszak C, de Vries-Brilland M et. al.

Apr 6th, 2022 - Iron deficiency (ID) is very common in patients with solid tumors and may cause symptoms such as fatigue. However, its impact on clinical outcomes is poorly described. The aim of this prospective monocentric cohort study was to evaluate the evolut...

see more →

Guidelines  1 results

Non-invasive diagnosis and follow-up of hyperferritinaemia.
https://doi.org/10.1016/j.clinre.2021.101762
Clinics and Research in Hepatology and Gastroenterology; Bardou-Jacquet E, Hamdi-Roze H et. al.

Aug 1st, 2021 - Increased serum ferritin is a very frequent cause of referral for which thorough evaluation is required to avoid unnecessary exploration and inaccurate diagnosis. Clinicians must thus know factors and tools that are relevant in this setting. Sever...

see more →

Clinicaltrials.gov  41 results

FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
https://clinicaltrials.gov/ct2/show/NCT05356325

May 2nd, 2022 - 1 Study populations 1.1) Study in patients with iron deficiency anemia with normal renal function. The study will be carried out in the serum samples of patients. All patients will be provided with the corresponding informed consent. Patients with...

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
https://clinicaltrials.gov/ct2/show/NCT01114139

Apr 21st, 2022 - This Phase III, randomized, double-blind, placebo-controlled, multicenter clinical study evaluated the safety and efficacy of ferumoxytol compared with placebo for the treatment of IDA, specifically in adult patients with IDA who have a history of...

Effect of Taking a Single Tablet of Iron on Insulin Secretion
https://clinicaltrials.gov/ct2/show/NCT05238987

Mar 2nd, 2022 - Oral iron supplementation is the treatment of choice in patients with iron deficiency anemia. In several developing countries, including India, iron is routinely supplemented to pregnant women, especially during the second and third trimesters of ...

Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma
https://clinicaltrials.gov/ct2/show/NCT05190263

Feb 15th, 2022 - Health care structure analysis and recruitment (phase 1): In a first step, data on care facilities treating patients in the above indica-tions in Germany will be collected (gastroenterology, gynecology, hema-tology/oncology, and pneumology hospita...

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis
https://clinicaltrials.gov/ct2/show/NCT04779593

Jul 19th, 2021 - Patients in maintenance treatment for HFE hemochromatosis since at least one year will be included in a two year study period and randomized in two groups experimental and control group. Because proton pump inhibitors are widely used as chronic me...

see more →

News  40 results

Use of High-Dose Iron in Dialysis in US Tracks PIVOTAL Trial
https://www.medscape.com/viewarticle/968908

Feb 22nd, 2022 - A little over 3 years ago, researchers reported findings from PIVOTAL, the largest prospective, randomized trial to assess an aggressive versus conservative iron-repletion strategy in patients with end-stage kidney disease on hemodialysis, in The ...

HF Prognosis Differs According to Iron Deficiency Definition
https://www.medscape.com/viewarticle/967225

Jan 25th, 2022 - There's overall agreement that iron deficiency is prevalent and portends a worse prognosis in patients with heart failure (HF), regardless of ejection fraction or anemia. What remains unclear, however, is which of the many definitions of iron defi...

Iron Deficiency Anemia Clinical Practice Guidelines (BSG, 2021)
https://www.medscape.com/viewarticle/959843

Sep 29th, 2021 - Guidelines for the management of patients with iron deficiency anemia (IDA) in adults were published in September 2021 by the British Society of Gastroenterology (BSG) in Gut.[1] Assessment Before investigation, iron deficiency should be confirmed...

High-Dose Iron Protects Dialysis Patients Against Classic MI
https://www.staging.medscape.com/viewarticle/932404

Jun 16th, 2020 - Proactive treatment with high-dose intravenous (IV) iron reduces the risk for classic atherothrombotic myocardial infarction — a type 1 MI — in dialysis patients, an analysis of data from the PIVOTAL trial shows. However, high-dose iron does not p...

High-Dose Iron Protects Dialysis Patients Against Classic MI
https://www.medscape.com/viewarticle/932404

Jun 16th, 2020 - Proactive treatment with high-dose intravenous (IV) iron reduces the risk for classic atherothrombotic myocardial infarction — a type 1 MI — in dialysis patients, an analysis of data from the PIVOTAL trial shows. However, high-dose iron does not p...

see more →

Patient Education  1 results see all →